{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:03:12Z","timestamp":1793908992182,"version":"4.8.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Surgical treatment for metastatic pathological femur fractures is associated with high mortality. Correct estimation of prognosis helps in determining the palliative value of surgical treatment and informs surgical decision. This study evaluates the risk factors for mortality in these patients who were surgically treated.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This is a retrospective study of 112 patients with surgical treatment of metastatic pathological femur fractures. Risk factors evaluated included age, ASA status, Charlson comorbidity index, preoperative serum albumin and haemoglobin, primary tumour site, presence of visceral metastases, presence of spinal metastases, time from diagnosis of cancer to occurrence of pathological fracture, type of surgical procedure performed, lesion and whether treatment was received for an actual or impending fracture. A Cox regression model was used to determine if these factors were independent significant factors for survival.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Mortality at 2\u2009years after surgical treatment of metastatic femoral fractures was 86%. Cox regression analysis of risk factors revealed that preoperative serum albumin and type primary tumour were independent risk factors for mortality. Presence of visceral metastases was strongly correlated to serum albumin levels.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Preoperative serum albumin level and primary tumour site are independent risk factors of survival in patients treated for pathological femur fractures. Serum albumin level may be used as a prognostic tool to guide treatment in this cohort of patients with high mortality rates.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13018-020-01632-7","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T09:02:58Z","timestamp":1585904578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Serum albumin level predicts survival after surgical treatment of metastatic femur fractures: a retrospective study"],"prefix":"10.1186","volume":"15","author":[{"given":"David Shaoen","family":"Sim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraya","family":"Zainul-Abidin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen Yilin","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu Sheng","family":"Seng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shern-En Evan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mann Hong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tet Sen","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Suang Bee","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"issue":"4","key":"1632_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1590\/S1807-59322006000400007","volume":"61","author":"DK Narazaki","year":"2006","unstructured":"Narazaki DK, de Alverga Neto CC, Baptista AM, Caiero MT, de Camargo OP. Prognostic factors in pathologic fractures secondary to metastatic tumors. Clinics. 2006 Aug;61(4):313\u201320.","journal-title":"Clinics."},{"key":"1632_CR2","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.1200\/JCO.2005.08.104","volume":"23","author":"SS Nathan","year":"2005","unstructured":"Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, et al. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol. 2005;23:6072\u201382.","journal-title":"J Clin Oncol."},{"key":"1632_CR3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1007\/s11999-016-5187-3","volume":"475","author":"JA Forsberg","year":"2017","unstructured":"Forsberg JA, Wedin R, Boland PJ, Healey JH. Can we estimate short- and intermediate-term survival in patients undergoing surgery for metastatic bone disease? Clin Orthop Relat Res. 2017;475:1252\u201361.","journal-title":"Clin Orthop Relat Res."},{"issue":"8","key":"1632_CR4","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.2106\/00004623-200408000-00011","volume":"86-A","author":"MM Schneiderbauer","year":"2004","unstructured":"Schneiderbauer MM, von Knoch M, Schleck CD, Harmsen WS, Sim FH, Scully SP. Patient survival after hip arthroplasty for metastatic disease of the hip. J Bone Joint Surg Am. 2004;86-A(8):1684\u20139.","journal-title":"J Bone Joint Surg Am."},{"issue":"4","key":"1632_CR5","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/TA.0b013e3181622bca","volume":"66","author":"K Sarahrudi","year":"2009","unstructured":"Sarahrudi K, Greitbauer M, Platzer P, Hausmann J-T, Heinz T, V\u00e9csei V. Surgical treatment of metastatic fractures of the femur: a retrospective analysis of 142 patients. J Trauma. 2009;66(4):1158\u201363.","journal-title":"J Trauma."},{"issue":"3","key":"1632_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/ans.12830","volume":"85","author":"T Hill","year":"2015","unstructured":"Hill T, D\u2019Alessandro P, Murray K, Yates P. Prognostic factors following pathological fractures. ANZ J Surg. 2015;85(3):159\u201363.","journal-title":"ANZ J Surg."},{"issue":"2","key":"1632_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1302\/0301-620X.98B2.36107","volume":"98-B","author":"MS S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen MS, Gerds TA, Hinds\u00f8 K, Petersen MM. Prediction of survival after surgery due to skeletal metastases in the extremities. Bone Joint J. 2016 Feb;98-B(2):271\u20137.","journal-title":"Bone Joint J."},{"issue":"sup311","key":"1632_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/00016470410001708270","volume":"75","author":"BH Hansen","year":"2004","unstructured":"Hansen BH, Keller J, Laitinen M, Berg P, Skjeldal S, Trovik C, et al. The Scandinavian Sarcoma Group skeletal metastasis register survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand. 2004;75(sup311):11\u20135.","journal-title":"Acta Orthop Scand"},{"issue":"2","key":"1632_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.injury.2013.09.025","volume":"45","author":"A Piccioli","year":"2014","unstructured":"Piccioli A, Rossi B, Scaramuzzo L, Spinelli MS, Yang Z, Maccauro G. Intramedullary nailing for treatment of pathologic femoral fractures due to metastases. Injury. 2014;45(2):412\u20137.","journal-title":"Injury"},{"key":"1632_CR10","unstructured":"Foster KW. Hip fractures in adults. UpToDate. 2017 Oct."},{"key":"1632_CR11","doi-asserted-by":"crossref","unstructured":"Araki N, Chuman H, Matsunobu T, Tanaka K, Katagiri H, Kunisada T, et al. Factors associated with the decision of operative procedure for proximal femoral bone metastasis: questionnaire survey to institutions participating the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group. J Orthop Sci. 22(5):938\u201345.","DOI":"10.1016\/j.jos.2017.05.012"},{"issue":"10","key":"1632_CR12","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1302\/0301-620X.100B10.BJJ-2018-0239.R1","volume":"100-B","author":"JJ Willeumier","year":"2018","unstructured":"Willeumier JJ, van de Sande MAJ, van der Wal RJP, Dijkstra PDS. Trends in the surgical treatment of pathological fractures of the long bones. Bone Joint J. 2018;100-B(10):1392\u20138.","journal-title":"Bone Joint J."},{"issue":"5","key":"1632_CR13","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/cam4.292","volume":"3","author":"H Katagiri","year":"2014","unstructured":"Katagiri H, Okada R, Takagi T, Takahashi M, Murata H, Harada H, et al. New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med. 2014;3(5):1359\u201367.","journal-title":"Cancer Med."},{"key":"1632_CR14","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.3928\/01477447-20160222-08","volume":"39","author":"SM Kreul","year":"2016","unstructured":"Kreul SM, Sorger JI, Rajamanickam VP, Heiner JP. Updated outcomes of prophylactic femoral fixation. Orthopedics. 2016;39:e346\u201352.","journal-title":"Orthopedics."},{"key":"1632_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1245\/s10434-015-4881-9","volume":"23","author":"Y Tsuda","year":"2016","unstructured":"Tsuda Y, Yasunaga H, Horiguchi H, Fushimi K, Kawano H, Tanaka S. Complications and postoperative mortality rate after surgery for pathological femur fracture related to bone metastasis: analysis of a nationwide database. Ann Surg Oncol. 2016;23:801\u201310.","journal-title":"Ann Surg Oncol."},{"issue":"15","key":"1632_CR16","doi-asserted-by":"publisher","first-page":"e3354","DOI":"10.1097\/MD.0000000000003354","volume":"95","author":"MS S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen MS, Hinds\u00f8 K, Hovgaard TB, Petersen MM. Extent of surgery does not influence 30-day mortality in surgery for metastatic bone disease: an observational study of a historical cohort. Hanaoka. K, ed. Medicine. 2016;95(15):e3354. https:\/\/doi.org\/10.1097\/MD.0000000000003354.","journal-title":"Medicine"},{"issue":"3","key":"1632_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5435\/JAAOS-22-03-193","volume":"22","author":"MB Cross","year":"2014","unstructured":"Cross MB, Yi PH, Thomas CF, Garcia J, Della Valle CJ. Evaluation of malnutrition in orthopaedic surgery. J Am Acad Orthop Surg. 2014 Mar;22(3):193\u20139.","journal-title":"J Am Acad Orthop Surg."},{"key":"1632_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.","journal-title":"Nutr J."},{"issue":"7","key":"1632_CR19","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00590-013-1299-6","volume":"24","author":"V Kumar","year":"2014","unstructured":"Kumar V, Alva A, Akkena S, Jones M, Murphy PN, Clough T. Are albumin and total lymphocyte count significant and reliable predictors of mortality in fractured neck of femur patients? Eur J Orthop Surg Traumatol. 2014;24(7):1193\u20136.","journal-title":"Eur J Orthop Surg Traumatol."},{"issue":"1","key":"1632_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1308\/003588413X13511609954815","volume":"95","author":"W Kieffer","year":"2013","unstructured":"Kieffer W, Rennie C, Gandhe A. Preoperative albumin as a predictor of one-year mortality in patients with fractured neck of femur. Annals of The Royal College of Surgeons of England. 2013;95(1):26\u20138.","journal-title":"Annals of The Royal College of Surgeons of England."},{"issue":"7","key":"1632_CR21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.injury.2011.12.008","volume":"43","author":"AS Laulund","year":"2012","unstructured":"Laulund AS, Lauritzen JB, Duus BR, Mosfeldt M, J\u00f8rgensen HL. Routine blood tests as predictors of mortality in hip fracture patients. Injury. 2012;43(7):1014\u201320.","journal-title":"Injury."},{"key":"1632_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4055\/cios.2017.9.1.116","volume":"9","author":"CK Krishnan","year":"2017","unstructured":"Krishnan CK, Han I, Kim H-S. Outcome after surgery for metastases to the pelvic bone: a single institutional experience. Clin Orthop Surg. 2017;9:116\u201325.","journal-title":"Clin Orthop Surg."},{"issue":"6","key":"1632_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/2192568217750125","volume":"8","author":"JT Cassidy","year":"2018","unstructured":"Cassidy JT, Baker JF, Lenehan B. The role of prognostic scoring systems in assessing surgical candidacy for patients with vertebral metastasis: a narrative review. Global Spine J. 2018 Sep;8(6):638\u201351.","journal-title":"Global Spine J."},{"key":"1632_CR24","first-page":"CD001880","volume":"11","author":"A Avenell","year":"2016","unstructured":"Avenell A, Smith TO, Curtain JP, Mak JC, Myint PK. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database Syst Rev. 2016;11:CD001880.","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-020-01632-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13018-020-01632-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-020-01632-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T23:34:17Z","timestamp":1617406457000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-020-01632-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1632"],"URL":"https:\/\/doi.org\/10.1186\/s13018-020-01632-7","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"assertion":[{"value":"7 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involves human data, and institutional review board approval was obtained (Singhealth CIRB 2015\/2134) before the start of this single-centre retrospective cohort study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}